ELAN PHARMACEUTICALS LLC has a total of 15 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Israel, EPO (European Patent Office) and Hong Kong. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SCIOS INC, PROBIODRUG AG and ABBVIE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Hong Kong | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Canada | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Animal care | |
#7 | Measuring microorganism processes | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Chilcote Tamie J | 5 |
#2 | Anderson John P | 5 |
#3 | Walker Donald | 5 |
#4 | Goldstein Jason | 5 |
#5 | Garofalo Albert | 3 |
#6 | Aubele Danielle | 3 |
#7 | Bowers Simeon | 1 |
#8 | Adler Marc | 1 |
#9 | Ye Xiaocong Michael | 1 |
#10 | Abushakra Susan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014150981A1 | Inhibitors of lrrk2 kinase activity | |
CA2912912A1 | Truncated fragments of alpha-synuclein in lewy body disease |